Maria Valencik Ph.D.: Experience/Publications

Associate Professor; Basic Science Coordinator

Department of Pharmacology

Selected publications

2004

  • Suarez, J., B. Gloss, D.D. Belke, Y. Hu, B. Scott, T. Dieterle, Y. Kim, M.L. Valencik, J.A. McDonald and W.H. Dillmann. . Doxycycline inducible expression of SERCA2a improves calcium handling and reverts cardiac dysfunction in pressure overload-induced cardiac hypertrophy. American Journal of Heart and Circulatory Physiology.
  • Russell, L.K., C.M. Mansfield, J.J. Lehman, A. Kovacs, M. Courtois, J.E. Saffitz, M.L. Valencik, J.A. McDonald, and D. P. Kelley. . Cardiac-specific induction of the transcriptional coactivator PGC-1a promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circulation Research. 94(4):525-33.

2002

  • Valencik ML, Keller RS, Loftus JC, and McDonald JA. . A lethal perinatal cardiac phenotype resulting from altered integrin function in cardiomyocytes. Journal of Cardiac Failure. 84, 262-72.

2001

  • Valencik ML, and McDonald JA. . Cardiac expression of a gain-of-function alpha(5)-integrin results in perinatal lethality. American Journal of Heart and Circulatory Physiology. 280H, 361-7.
  • Valencik ML, and McDonald JA. . Codon optimization markedly improves doxycycline regulated gene expression in the mouse heart. Transgenic Research. 10, 269-75.
  • Keller RS, Shai SY, Babbitt CJ, Pham CG, Solaro RJ, Valencik ML, Loftus JC and Ross RS. . Disruption of integrin function in the murine myocardium leads to perinatal lethality, fibrosis and abnormal cardiac performance. American Journal of Pathology 158, 1079-90.

The University of Nevada, Reno School of Medicine is dedicated to protecting the privacy and security of your medical information. Please do not use email to communicate your personal health information to physicians or other patient care staff.